Insider screener

Period: 12 months Type of trade: Sold × Plan: Scheduled (10b5-1) × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

22,718 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

22,718 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

22,718 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

22,718 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
22,718 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
22,718 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

22,718 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
28 Jul 2026
Lipesky Scott D. EVP and COO
Sold on a plan
$1.05M 10,000 at 105.00
5.5%
Planned (10b5-1)
28 Jul 2026
BIDZOS D JAMES Exec. Chairman, Pres, & CEO
Sold on a plan 4×
$927.96K 3,300 at 281.20
0.8%
Planned (10b5-1)
28 Jul 2026
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$909.57K 3,580 at 254.07
3.4%
Planned (10b5-1)
28 Jul 2026
Liaw Jeffrey Chief Executive Officer
Sold on a plan
$845.95K 27,745 at 30.49
21.8%
Planned (10b5-1)
28 Jul 2026
Quigg Andrew J VP and Chief Financial Officer
Sold on a plan
$769.78K 3,499 at 220.00
7.6%
Planned (10b5-1)
28 Jul 2026
Zeidel Darren General Counsel
Sold on a plan 3×
$717.75K 1,900 at 377.76
14.2%
Planned (10b5-1)
28 Jul 2026
DUCA MAURICE J 10% owner
Sold on a plan 3×
$634.50K 3,500 at 181.29
4.3%
Planned (10b5-1)
28 Jul 2026
Hatto Christopher Vice President & CAO
Sold on a plan
$620.55K 6,895 at 90.00
26.7%
Planned (10b5-1)
28 Jul 2026
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 3×
$614.34K 2,419 at 253.96
4.3%
Planned (10b5-1)
28 Jul 2026
Sold on a plan
$490.20K 6,000 at 81.70
0.4%
Planned (10b5-1)
28 Jul 2026
DELANEY MARK E SVP & Chief Commercial Officer
Sold on a plan
$376.29K 1,600 at 235.18
13.4%
Planned (10b5-1)
28 Jul 2026
Kroeker Nathan Chief Commercial Officer
Sold on a plan
$371.00K 110,417 at 3.36
11.1%
Planned (10b5-1)
28 Jul 2026
Kopetsky Amanda Brooke CHIEF HUMAN RESOURCES OFFICER
Sold on a plan
$363.74K 13,472 at 27.00
64.8%
Sold half or more
28 Jul 2026
Sold on a plan
$327.61K 19,855 at 16.50
27.0%
Planned (10b5-1)
28 Jul 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$305.90K 1,204 at 254.07
0.9%
Planned (10b5-1)
28 Jul 2026
McQuarrie David P. Chief Commercial Officer
Sold on a plan
$294.46K 10,524 at 27.98
11.4%
Planned (10b5-1)
28 Jul 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$254.83K 1,003 at 254.07
0.6%
Planned (10b5-1)
28 Jul 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$236.54K 931 at 254.07
0.5%
Planned (10b5-1)
28 Jul 2026
Norwalk Leslie V Director
Sold on a plan
$227.51K 1,250 at 182.01
44.0%
Planned (10b5-1)
28 Jul 2026
Sold on a plan
$216.00K 1,125 at 192.00
6.4%
Planned (10b5-1)
28 Jul 2026
Niri Sagi Chief Financial Officer
Sold on a plan
$184.77K 17,578 at 10.51
12.2%
Planned (10b5-1)
28 Jul 2026
Nonko Eugene Director · indirect
Sold on a plan
$149.38K 10,843 at 13.78
1.0%
Planned (10b5-1)
28 Jul 2026
Eltoukhy Adam SEE REMARKS
Sold on a plan
$135.16K 3,653 at 37.00
0.9%
Planned (10b5-1)
28 Jul 2026
Remer Eric Richard Chief Executive Officer
Sold on a plan
$126.68K 10,491 at 12.07
0.2%
Planned (10b5-1)
28 Jul 2026
Wang Yanjun CCO and GC · indirect
Sold on a plan 4×
$125.68K 1,200 at 104.73
5.0%
Planned (10b5-1)
28 Jul 2026
Dowling Ruth T EVP, Chief Admin Ofr, GC & Sec
Sold on a plan
$116.13K 685 at 169.54
2.3%
Planned (10b5-1)
28 Jul 2026
Puri Sumeet Chief Accounting Officer
Sold on a plan
$98.00K 29,167 at 3.36
12.6%
Planned (10b5-1)
28 Jul 2026
Briggs Andrew J Director
Sold on a plan
$94.77K 3,000 at 31.59
3.1%
Planned (10b5-1)
28 Jul 2026
Nonko Eugene Director
Sold on a plan
$91.78K 6,622 at 13.86
0.8%
Planned (10b5-1)
28 Jul 2026
Sold on a plan
$90.16K 3,595 at 25.08
0.0%
Planned (10b5-1)
28 Jul 2026
Brown Brian Michael Chief Legal Officer
Sold on a plan
$63.10K 4,824 at 13.08
0.6%
Planned (10b5-1)
28 Jul 2026
Zeltser Guy Chief Financial Officer
Sold on a plan
$51.71K 1,669 at 30.98
1.4%
Planned (10b5-1)
28 Jul 2026
Sheena Jonathan Director
Sold on a plan
$48.53K 191 at 254.07
0.1%
Planned (10b5-1)
28 Jul 2026
Burke Mary Lou COO North America Center Ops
Sold on a plan
$40.00K 500 at 80.00
1.5%
Planned (10b5-1)
28 Jul 2026
Yeh Jenny C SVP & Chief Legal Officer
Sold on a plan
$38.65K 1,757 at 22.00
0.7%
Planned (10b5-1)
28 Jul 2026
Kannan Molly D CAO & Corporate Controller
Sold on a plan
$16.00K 500 at 32.00
2.0%
Planned (10b5-1)
28 Jul 2026
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER
Sold on a plan
$13.16K 4,928 at 2.67
7.3%
Planned (10b5-1)
28 Jul 2026
GALLAGHER JOHN R Chief Operating Officer
Sold on a plan
$10.81K 431 at 25.08
1.3%
Planned (10b5-1)
28 Jul 2026
Brosius Mark EVP & Chief Mfg and Supply Cha
Sold on a plan
$10.24K 28 at 365.58
2.0%
Planned (10b5-1)
28 Jul 2026
Szczepaniak Mark R Chief Financial Officer · indirect
Sold on a plan
$7.20K 400 at 18.00
0.6%
Planned (10b5-1)
28 Jul 2026
RAIGUEL DARREN S CHIEF OPERATING OFFICER · indirect
Sold on a plan
$6.05K 65 at 93.11
0.1%
Planned (10b5-1)
27 Jul 2026
Gebbia Joseph Director · indirect
Sold on a plan 5×
$38.61M 265,000 at 145.70
12.7%
Planned (10b5-1)
27 Jul 2026
McBee Brannin Chief Development Officer
Sold on a plan 5×
$10.23M 144,000 at 71.04
30.8%
Planned (10b5-1)
27 Jul 2026
Barra Mary T Chair & CEO
Sold on a plan 2×
$8.90M 104,361 at 85.32
16.3%
Planned (10b5-1)
27 Jul 2026
Griffith Susan Patricia President and CEO
Sold on a plan
$7.94M 37,338 at 212.71
6.7%
Planned (10b5-1)
27 Jul 2026
McBee Brannin Chief Development Officer · indirect
Sold on a plan 30×
$7.53M 106,000 at 71.04
100%
Sold half or more
27 Jul 2026
Venker Eric President & Immunovant CEO
Sold on a plan
$6.99M 200,000 at 34.95
11.0%
Planned (10b5-1)
27 Jul 2026
Kersten Dirk Director · indirect
Sold on a plan 2×
$6.67M 261,460 at 25.51
6.8%
Planned (10b5-1)
27 Jul 2026
Cheng Chi Fung Chief Technology Officer · indirect
Sold on a plan 20×
$5.65M 27,500 at 205.54
0.5%
Planned (10b5-1)
27 Jul 2026
ROTHBLATT MARTINE A Chairperson & CEO · indirect
Sold on a plan 9×
$5.04M 9,500 at 530.42
2.8%
Planned (10b5-1)
Showing 5,251–5,300 of 22,718. ← Newer Page 106 of 455 Older →